Non-Laboratory-based Cannabis Testing Market Analysis

Non-Laboratory-based Cannabis Testing Market Analysis   

Based on technology, the market is segmented into chromatography, spectroscopy, and other technologies. The spectroscopy segment is further sub-segmented into near-infrared (NIR) spectroscopy and other spectroscopy. As of 2022, the spectroscopy segment held the largest market share, accounting for 30 million of the total market revenue. This segment is expected to continue growing at a rate of 14.9% from 2023 to 2032. Spectroscopy provides the unique capability of simultaneously measuring various parameters in cannabis samples, including the levels of cannabinoids such as THC and CBD, moisture content, and the presence of contaminants. This comprehensive analytical capacity is particularly appealing to users who seek a holistic understanding of their cannabis products. Additionally, spectroscopy-based devices offer rapid measurements, often delivering results within minutes.
 

Based on test type, the non-laboratory-based cannabis testing market is classified into potency testing, water testing, moisture testing, and other test types. The potency testing held significant market share of 64.6% in 2022. Portable non-laboratory-based cannabis testing devices designed for potency testing are playing a pivotal role in revolutionizing the way cannabis products are assessed for their cannabinoid content. These devices offer several distinct advantages, making them valuable tools in the cannabis industry. The portable devices enhance accessibility to cannabis potency analysis. Portable potency testing devices are designed to be user-friendly, requiring minimal training. This ensures that individuals with varying levels of technical expertise can utilize the technology effectively, further accessing to potency testing capabilities.
 

Europe non-laboratory-based cannabis testing market is projected to reach USD 82.6 million by 2032. On-site quality control assessments are crucial for ensuring that cannabis products meet regulatory standards and comply with Germany's strict legal requirements. Portable devices empower cultivators and dispensaries to conduct immediate quality checks, contributing to product consistency and safety. Also, Germany follows a pharmaceutical model for medical cannabis distribution, with products dispensed through pharmacies. This pharmaceutical approach demands rigorous quality control, including testing, to maintain product consistency and safety.